CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Tcr2 Therapeutics Inc   (TCRR)
Other Ticker:  
 

Cumulative Tcr2 Therapeutics Inc 's Quick Ratio for Trailing Twelve Months Period

TCRR's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

TCRR Quick Ratio for Trailing Twelve Months Period

 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Current Liabilities Growth 53.8 % 244.32 % 122.11 % 158.08 % 193.38 %
Y / Y Cash & cash equivalent Growth -52.49 % -43.83 % -40.49 % -35.01 % -30.33 %
Quick Ratio for Trailing Twelve Months Period 3.44 4.49 7.05 9.56 13.72
Total Ranking # 816 # 759 # 535 # 470 # 318
Seq. Current Liabilities Growth -25.89 % 74.59 % -4.87 % 24.96 % 65.91 %
Seq. Cash & cash equivalent Growth -26.06 % -15.23 % -14.67 % -11.18 % -12.58 %

TCRR Segments >> Back to TCRR Financial Strength Comparisons >> Compare TCRR Quick Ratio to its Competitors

Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Mar 31 2023
On the trailing twelve months basis Due to cut in Current Liabilities in the I. Quarter to $47 millions, average cumulative Quick Ratio for Trailing Twelve Months Period decreased to 3.44 below Tcr2 Therapeutics Inc average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 120 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Tcr2 Therapeutics Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about TCRR
Quick Ratio TCRR in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 121
Sector # 614
S&P 500 # 1059


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
27.78 15.31 1.67
(Mar 31 2021)   (Mar 31 2019)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2023, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Autolus Therapeutics Plc  9.25 
Scholar Rock Holding Corp  9.12 
Allovir Inc   9.05 
Vectivbio Holding Ag  8.95 
Tenaya Therapeutics Inc   8.92 
Inhibrx Inc   8.71 
Inmune Bio Inc   8.65 
Solid Biosciences Inc   8.65 
Tscan Therapeutics Inc   8.60 
Avrobio Inc   8.55 
Atyr Pharma Inc   8.54 
Entera Bio Ltd   8.53 
Dyadic International Inc  8.44 
Editas Medicine Inc   8.43 
Black Diamond Therapeutics Inc   8.42 
Invivyd Inc   8.20 
Ginkgo Bioworks Holdings Inc   8.18 
In8bio Inc   8.16 
Kodiak Sciences Inc   8.11 
Ocugen Inc   8.07 
Jounce Therapeutics inc   7.78 
Inhibikase Therapeutics Inc   7.72 
Surface Oncology Inc   7.60 
Ambrx Biopharma Inc   7.39 
Cortexyme Inc   7.36 
Iovance Biotherapeutics Inc   7.14 
Elevation Oncology inc   7.13 
Compugen Ltd  7.02 
Zura Bio Limited  6.98 
Dbv Technologies S a   6.76 




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com